These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 17046402)

  • 1. Peptide-based inhibitors of amyloid assembly.
    Sciarretta KL; Gordon DJ; Meredith SC
    Methods Enzymol; 2006; 413():273-312. PubMed ID: 17046402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A molecular dynamics study of the interaction of D-peptide amyloid inhibitors with their target sequence reveals a potential inhibitory pharmacophore conformation.
    Esteras-Chopo A; Morra G; Moroni E; Serrano L; Lopez de la Paz M; Colombo G
    J Mol Biol; 2008 Oct; 383(1):266-80. PubMed ID: 18703072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity.
    Kapurniotu A; Schmauder A; Tenidis K
    J Mol Biol; 2002 Jan; 315(3):339-50. PubMed ID: 11786016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial separation of beta-sheet domains of beta-amyloid: disruption of each beta-sheet by N-methyl amino acids.
    Sciarretta KL; Boire A; Gordon DJ; Meredith SC
    Biochemistry; 2006 Aug; 45(31):9485-95. PubMed ID: 16878983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switch-peptides: design and characterization of controllable super-amyloid-forming host-guest peptides as tools for identifying anti-amyloid agents.
    Camus MS; Dos Santos S; Chandravarkar A; Mandal B; Schmid AW; Tuchscherer G; Mutter M; Lashuel HA
    Chembiochem; 2008 Sep; 9(13):2104-12. PubMed ID: 18683159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of peptide-based inhibitors of human islet amyloid polypeptide fibrillogenesis.
    Scrocchi LA; Chen Y; Waschuk S; Wang F; Cheung S; Darabie AA; McLaurin J; Fraser PE
    J Mol Biol; 2002 May; 318(3):697-706. PubMed ID: 12054816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New strategy for the generation of specific D-peptide amyloid inhibitors.
    Esteras-Chopo A; Pastor MT; Serrano L; López de la Paz M
    J Mol Biol; 2008 Apr; 377(5):1372-81. PubMed ID: 18328503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of amyloid fibril formation of human amylin by N-alkylated amino acid and alpha-hydroxy acid residue containing peptides.
    Rijkers DT; Höppener JW; Posthuma G; Lips CJ; Liskamp RM
    Chemistry; 2002 Sep; 8(18):4285-91. PubMed ID: 12298020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and activity of fibrillogenesis peptide inhibitors related to the 17-21 beta-amyloid sequence.
    Giordano C; Masi A; Pizzini A; Sansone A; Consalvi V; Chiaraluce R; Lucente G
    Eur J Med Chem; 2009 Jan; 44(1):179-89. PubMed ID: 18501995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-assembly of amylin(20-29) amide-bond derivatives into helical ribbons and peptide nanotubes rather than fibrils.
    Elgersma RC; Meijneke T; Posthuma G; Rijkers DT; Liskamp RM
    Chemistry; 2006 May; 12(14):3714-25. PubMed ID: 16528792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The world of beta- and gamma-peptides comprised of homologated proteinogenic amino acids and other components.
    Seebach D; Beck AK; Bierbaum DJ
    Chem Biodivers; 2004 Aug; 1(8):1111-239. PubMed ID: 17191902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of peptides that form amyloid-like fibrils capturing amyloid beta1-42 peptides.
    Sato J; Takahashi T; Oshima H; Matsumura S; Mihara H
    Chemistry; 2007; 13(27):7745-52. PubMed ID: 17605154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cyclic peptide inhibitor of apoC-II peptide fibril formation: mechanistic insight from NMR and molecular dynamics analysis.
    Griffin MD; Yeung L; Hung A; Todorova N; Mok YF; Karas JA; Gooley PR; Yarovsky I; Howlett GJ
    J Mol Biol; 2012 Mar; 416(5):642-55. PubMed ID: 22244853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlling amyloid growth in multiple dimensions.
    Dong J; Lu K; Lakdawala A; Mehta AK; Lynn DG
    Amyloid; 2006 Dec; 13(4):206-15. PubMed ID: 17107881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing peptide inhibitors for oligomerization and toxicity of Alzheimer's beta-amyloid peptide.
    Austen BM; Paleologou KE; Ali SA; Qureshi MM; Allsop D; El-Agnaf OM
    Biochemistry; 2008 Feb; 47(7):1984-92. PubMed ID: 18189413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-N intramolecular acyl migration reaction in the development of prodrugs and the synthesis of difficult sequence-containing bioactive peptides.
    Sohma Y; Hayashi Y; Skwarczynski M; Hamada Y; Sasaki M; Kimura T; Kiso Y
    Biopolymers; 2004; 76(4):344-56. PubMed ID: 15386265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new amyloid-like beta-aggregate with amyloid characteristics, except fibril morphology.
    Chang ES; Liao TY; Lim TS; Fann W; Chen RP
    J Mol Biol; 2009 Jan; 385(4):1257-65. PubMed ID: 19041877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switch-peptides as folding precursors in self-assembling peptides and amyloid fibrillogenesis.
    Tuchscherer G; Chandravarkar A; Camus MS; Bérard J; Murat K; Schmid A; Mimna R; Lashuel HA; Mutter M
    Biopolymers; 2007; 88(2):239-52. PubMed ID: 17206626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide inhibitors of beta-amyloid aggregation.
    Doig AJ
    Curr Opin Drug Discov Devel; 2007 Sep; 10(5):533-9. PubMed ID: 17786851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.